Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
단면연구
4/5 보강
TL;DR
A high prevalence of comorbid autoimmune diseases in patients with vitiligo is observed and several new associations are reported, including Guillain-Barre syndrome, alopecia areata, and Sjögren syndrome.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
1873 patients with vitiligo seen between January 2002 and October 2012 at the Henry Ford Health System in Detroit, MI.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
we found a higher prevalence of thyroid disease (12.
📑 코퍼스 인용 관계
· 인용됨 6
📑 인용한 논문 (6) ▾
- Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopec… Skin appendage disorders · 2025
- Association of Vitiligo With Autoimmune Disorders: A Bidirectional Two-Sample and Summary-… Journal of cosmetic dermatology · 2025
- Co-regulatory mechanisms and potential markers of oxidative stress-related genes in vitili… Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid… Annals of dermatology · 2019
- Thyroid diseases and skin autoimmunity. Reviews in endocrine & metabolic disorders · 2018
- Understanding autoimmunity of vitiligo and alopecia areata. Current opinion in pediatrics · 2016
연도별 인용 (2016–2026) · 합계 193
OpenAlex 토픽 ·
melanin and skin pigmentation
Systemic Lupus Erythematosus Research
Ocular Diseases and Behçet’s Syndrome
Abstract 🌐 Abstract
[BACKGROUND] Few large-scale studies have quantified the burden of comorbid autoimmune diseases in patients with vitiligo.
[OBJECTIVE] We sought to determine the prevalence of comorbid autoimmune diseases in patients with vitiligo.
[METHODS] We conducted a manual chart review on a cohort of 1873 patients with vitiligo seen between January 2002 and October 2012 at the Henry Ford Health System in Detroit, MI. Patients were excluded if they had fewer than 2 dermatology notes (N = 595) or if they were never given a diagnosis of vitiligo by a dermatologist (N = 180).
[RESULTS] Of 1098 patients with vitiligo, nearly 20% had at least 1 comorbid autoimmune disease. Compared with the general US population, we found a higher prevalence of thyroid disease (12.9%, P < .001), alopecia areata (3.8%, P < .001), inflammatory bowel disease (0.9%, P = .046), pernicious anemia (0.5%, P = .007), systemic lupus erythematosus (0.3%, P = .048), Guillain-Barre syndrome (0.3%, P < .001), discoid lupus (0.2%, P = .003), linear morphea (0.2%, P < .001), myasthenia gravis (0.2%, P = .002), and Sjögren syndrome (0.2%, P = .011).
[LIMITATIONS] The study lacked a control group. This was a single-institution study with possible selection bias, and thus the findings may not be representative of the overall population of patients with vitiligo.
[CONCLUSIONS] We observed a high prevalence of comorbid autoimmune diseases in patients with vitiligo and report several new associations.
[OBJECTIVE] We sought to determine the prevalence of comorbid autoimmune diseases in patients with vitiligo.
[METHODS] We conducted a manual chart review on a cohort of 1873 patients with vitiligo seen between January 2002 and October 2012 at the Henry Ford Health System in Detroit, MI. Patients were excluded if they had fewer than 2 dermatology notes (N = 595) or if they were never given a diagnosis of vitiligo by a dermatologist (N = 180).
[RESULTS] Of 1098 patients with vitiligo, nearly 20% had at least 1 comorbid autoimmune disease. Compared with the general US population, we found a higher prevalence of thyroid disease (12.9%, P < .001), alopecia areata (3.8%, P < .001), inflammatory bowel disease (0.9%, P = .046), pernicious anemia (0.5%, P = .007), systemic lupus erythematosus (0.3%, P = .048), Guillain-Barre syndrome (0.3%, P < .001), discoid lupus (0.2%, P = .003), linear morphea (0.2%, P < .001), myasthenia gravis (0.2%, P = .002), and Sjögren syndrome (0.2%, P = .011).
[LIMITATIONS] The study lacked a control group. This was a single-institution study with possible selection bias, and thus the findings may not be representative of the overall population of patients with vitiligo.
[CONCLUSIONS] We observed a high prevalence of comorbid autoimmune diseases in patients with vitiligo and report several new associations.
- 표본수 (n) 595
- p-value P < .001
A high prevalence of comorbid autoimmune diseases in patients with vitiligo is observed and several new associations are reported, including Guillain-Barre syndrome, alopecia areata, and Sjögren syndr
APA 7
Gill, L., Zarbo, A., Isedeh, P., Jacobsen, G., Lim, H. W., & Hamzavi, I. (2016). Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.. Journal of the American Academy of Dermatology, 74(2), 295-302. https://doi.org/10.1016/j.jaad.2015.08.063
Vancouver
Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. Jour. Amer. Acad. Derm.. 2016;74(2):295-302. doi:10.1016/j.jaad.2015.08.063
AMA 11
Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. Jour. Amer. Acad. Derm.. 2016;74(2):295-302. doi:10.1016/j.jaad.2015.08.063
Chicago
Gill, L., Zarbo, A., Isedeh, P., Jacobsen, G., Lim, H. W., and Hamzavi, I.. 2016. "Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study." Journal of the American Academy of Dermatology 74 (2): 295-302. https://doi.org/10.1016/j.jaad.2015.08.063
MLA 9
Gill, L., et al. "Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study." Journal of the American Academy of Dermatology, vol. 74, no. 2, 2016, pp. 295-302. doi:10.1016/j.jaad.2015.08.063.
PMID
26518171 ↗
추출된 의학 개체 (NER)
상태/진단
원형 탈모증 alopecia areata
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | alopecia areata
|
원형 탈모증 | dict | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Adolescent
- Adult
- Aged
- 80 and over
- Alopecia Areata
- Anemia
- Pernicious
- Autoimmune Diseases
- Body Surface Area
- Child
- Preschool
- Comorbidity
- Cross-Sectional Studies
- Female
- Graves Disease
- Guillain-Barre Syndrome
- Hashimoto Disease
- Humans
- Hyperthyroidism
- Hypothyroidism
- Inflammatory Bowel Diseases
- Lupus Erythematosus
- Discoid
- Systemic
… 외 19개
인용 관계
그래프 OA 노드: 5/6 (83%)
· 참조 0편 · 후속 5편
이 논문을 인용한 후속 연구 6
- Understanding autoimmunity of vitiligo and alopecia areata.
- Co-regulatory mechanisms and potential markers of oxidative stress-related genes in vitiligo and alo…
- Thyroid diseases and skin autoimmunity.
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease a…
- Association of Vitiligo With Autoimmune Disorders: A Bidirectional Two-Sample and Summary-Based Mend…
- Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata:…
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- 피나스테리드가 전립선암 발생에 미치는 영향.
- COVID-19의 50가지 이상의 장기 후유증: 체계적 문헌고찰 및 메타분석.
- 양성 전립선 비대증의 임상적 진행에 대한 doxazosin, finasteride 및 병용 요법의 장기 효과.
- 양성 전립선 비대증 환자에서 finasteride의 효과. The Finasteride Study Group.
- 양성 전립선 비대증 남성에서 급성 요폐의 위험과 수술적 치료 필요성에 대한 finasteride의 효과. Finasteride Long-Term Efficacy and Safety Study Group.
- 원형 탈모에 대한 전장유전체 연관성 연구는 선천면역과 적응면역 모두의 관여를 시사한다.
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Alopecia areata.
TL;DRAlopecia areata is difficult to manage medically, but recent advances in understanding the molecular mechanisms have revealed new treatments and the possibility of remission in the…
-
Epidemiology and burden of alopecia areata: a systematic review.
TL;DRAA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approxi…
-
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
TL;DRIn two phase 3 trials involving patients with severe alopecia areata, oral baricitinib was superior to placebo with respect to hair regrowth at 36 weeks.
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
TL;DRAlthough a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select ap…
-
Hair follicle immune privilege and its collapse in alopecia areata.
TL;DRA key goal for effective AA management is the re‐establishment of a functional HF IP, which will also provide superior protection from disease relapse, and may confer increased sus…